GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic®, Wegovy®, Mounjaro®, but with reduced risk of adverse events) discovered by researchers at Syracuse University. Vancouver, British Columbia–(Newsfile Corp. – February 23, 2026) – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (“SureNano” or the “Company”) is pleased …
Read More »
Breaking News
- Navigating Market Shifts: How Slower Private Sector Growth Impacts Your Portfolio
- RBI Monetary Policy June 2026: Why a Steady Repo Rate Matters to Your Wallet
- Decoding India’s Economic Health: A Closer Look at the June 2026 HSBC Flash PMI Data
- Future-Forward Conversations on Climate, Capital and Community at London Climate Action Week (LCAW) 2026, hosted by Women Inspiring Network (WIN)
- Shri Physio & Rehab Hosts Special Face Yoga and Meditation Session for Doctors on Doctor’s Day
- Sierra Madre Announces AGM Results
- Eureka Engages Winning Media LLC for Investor Awareness Services
- Ionik Announces Closing of New US$100 Million Credit Facilities and Completion of Debt Reorganization
- Coyote Copper Announces Edited Closing of Its Oversubscribed Financing
- MHP Sales Manager Launches Weekly “WoW Performance Review” Reporting for Mobile Home Parks
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar